Skip to main content
. 2022 Oct 14;36:103230. doi: 10.1016/j.nicl.2022.103230

Table 1.

Demographic and clinical characteristics of subjects.

Variables R-MDD NR-MDD HC T/F/Z/χ2 P
Numbers of subjects 31 35 57
Age 29.77 ± 10.54 25.83 ± 8.14 30.51 ± 7.76 3.355 0.038a
Gender (male/female) 13/18 12/23 26/31 1.150 0.563b
Education (years) 12.13 ± 3.16 13.29 ± 3.04 −1.513 0.135c
Course of disease (months) 29.15 ± 28.01 26.67 ± 27.45 0.362 0.719c
First-episode of depression (yes/no) 16/15 19/16 0.047 0.828b
Age at onset(years) 27.45 ± 10.53 23.71 ± 8.22 −1.630 0.103d
Heavy alcohol users(yes/no) 2/29 3/32 0.558e
Baseline HAMD-17 22.39 ± 4.37 23.74 ± 4.92 −1.128 0.259d
Baseline HAMA-14 17.00 ± 6.23 23.11 ± 5.97 −4.069 0.001c
Antidepressant regimen(Escitalopram/Venlafaxine) 16/15 14/21 0.894 0.344b
Fluoxetine equivalent dosage regimen(mg) 27.74 ± 12.96 31.29 ± 13.68 −1.039 0.299d

Abbreviations: R, remitters; NR, Non-remitters; MDD, major depressive disorder; HC, healthy controls; HAMD-17, 17-item Hamilton Depression Rating Scale; HAMA-14, Hamilton Anxiety Scale.

a

One-way ANOVA.

b

Chi-square test.

c

Two-sample t-test.

d

Mann-Whitney U.

e

Fisher’s exact test.